Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01711307
Other study ID # Version1
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date October 1, 2012
Est. completion date June 30, 2020

Study information

Verified date July 2020
Source Nova Scotia Health Authority
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed trial is a multi-centre prospective randomized controlled trial comparing outcomes of patients with acute Achilles tendon ruptures treated either non-operatively or with open operative tendon repair. All patients will undergo accelerated functional rehabilitation. The primary outcome measure is Achilles tendon re-rupture rate.


Description:

Equivalent clinical outcomes to surgical repair; reduced morbidity and disability to subjects through elimination of a surgical repair; reduction of cost to patients by eliminating need for surgery.


Recruitment information / eligibility

Status Terminated
Enrollment 220
Est. completion date June 30, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Complete mid-substance rupture of the Achilles tendon as diagnosed on clinical exam

- Present for initial assessment and treatment with application of a plantar-flexed cast within 48 hours of their injury.

- Referred to one of the participating orthopaedics surgeons in a timely fashion so as to allow for further treatment (operative repair or initiation of the rehabilitation protocol) within 14 days of their injury.

Exclusion Criteria:

- Open Achilles injury

- Achilles injury that is not a mid-substance tendon injury

- Any additional injury to the ipsilateral lower extremity

- Contraindication to surgery or anesthetic

- (Physical or mental) that may interfere with compliance with the rehabilitation protocol

- Any known factor for increased risk of Achilles tendon rupture (i.e. diabetes mellitus, immunosuppressive therapy including local or systemic steroids, and fluoroquinolone use).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
operative

non-operative
casting within 48 hrs

Locations

Country Name City State
Canada Halifax Infirmary Halifax Nova Scotia

Sponsors (2)

Lead Sponsor Collaborator
Mark Glazebrook Nova Scotia Health Authority

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Operative vs non operative Treatment of acute ruptures of Achilles tendon. The primary outcome measure is Achilles tendon re-rupture rate 1 year
Secondary Operative vs. Non-Operative Treatment of Acute Ruptures of the Achilles Tendon 1. The Achilles tendon Total Rupture Score (ATRS) 2 year
See also
  Status Clinical Trial Phase
Withdrawn NCT04114708 - MRI Review of ACLR With and Without Lateral Extra-articular Tenodesis N/A